UiPath (PATH$PATH
) share rebounds after heavy selling as Citi analyst flags a potential buy opportunity
Key highlights
Citi launched coverage of UiPath (PATH) with a "Buy" recommendation and a price target of $23
PATH shares fell 16% over the previous week, recording the worst weekly performance in more than four months
Bank of America raised its price target to $15 while keeping its stance at "Underperform"
Truist lifted its target to $17, while TD Cowen raised it to $16—both kept their "Hold" ratings
Second-quarter revenue rose 13% to $410.26 million, exceeding consensus estimates of $397.8 million
UiPath (PATH) received a bullish endorsement from Citi analysts on Tuesday, as the investment bank initiated coverage of the stock with a recommendation
🤑
) share rebounds after heavy selling as Citi analyst flags a potential buy opportunity
Key highlights
Citi launched coverage of UiPath (PATH) with a "Buy" recommendation and a price target of $23
PATH shares fell 16% over the previous week, recording the worst weekly performance in more than four months
Bank of America raised its price target to $15 while keeping its stance at "Underperform"
Truist lifted its target to $17, while TD Cowen raised it to $16—both kept their "Hold" ratings
Second-quarter revenue rose 13% to $410.26 million, exceeding consensus estimates of $397.8 million
UiPath (PATH) received a bullish endorsement from Citi analysts on Tuesday, as the investment bank initiated coverage of the stock with a recommendation
🤑
